NK cells and macrophages express FcγRIIIa in HER2+ breast cancer and TNBC, and FcγRIIIa+ NK cell and classically activated macrophage infiltration at baseline are associated with subsequent trastuzumab response. Here, FCGR3A is linked to breast carcinoma.